601 related articles for article (PubMed ID: 15641797)
1. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
[TBL] [Abstract][Full Text] [Related]
2. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
[TBL] [Abstract][Full Text] [Related]
3. Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface.
Majumder R; Weinreb G; Lentz BR
Biochemistry; 2005 Dec; 44(51):16998-7006. PubMed ID: 16363813
[TBL] [Abstract][Full Text] [Related]
4. A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.
Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
Blood; 2008 Oct; 112(7):2795-802. PubMed ID: 18587009
[TBL] [Abstract][Full Text] [Related]
5. Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va.
Srivastava A; Quinn-Allen MA; Kim SW; Kane WH; Lentz BR
Biochemistry; 2001 Jul; 40(28):8246-55. PubMed ID: 11444970
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
7. Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.
Kim SW; Ortel TL; Quinn-Allen MA; Yoo L; Worfolk L; Zhai X; Lentz BR; Kane WH
Biochemistry; 1999 Aug; 38(35):11448-54. PubMed ID: 10471296
[TBL] [Abstract][Full Text] [Related]
8. Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex.
Nicolaes GA; Villoutreix BO; Dahlbäck B
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):89-100. PubMed ID: 10691103
[TBL] [Abstract][Full Text] [Related]
9. Soluble phosphatidylserine triggers assembly in solution of a prothrombin-activating complex in the absence of a membrane surface.
Majumder R; Weinreb G; Zhai X; Lentz BR
J Biol Chem; 2002 Aug; 277(33):29765-73. PubMed ID: 12045194
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
[TBL] [Abstract][Full Text] [Related]
11. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
[TBL] [Abstract][Full Text] [Related]
12. Completed three-dimensional model of human coagulation factor va. Molecular dynamics simulations and structural analyses.
Orban T; Kalafatis M; Gogonea V
Biochemistry; 2005 Oct; 44(39):13082-90. PubMed ID: 16185076
[TBL] [Abstract][Full Text] [Related]
13. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.
Majumder R; Koklic T; Rezaie AR; Lentz BR
Biochemistry; 2013 Jan; 52(1):143-51. PubMed ID: 23214401
[TBL] [Abstract][Full Text] [Related]
15. Functional mapping of charged residues of the 82-116 sequence in factor Xa: evidence that lysine 96 is a factor Va independent recognition site for prothrombin in the prothrombinase complex.
Manithody C; Rezaie AR
Biochemistry; 2005 Aug; 44(30):10063-70. PubMed ID: 16042383
[TBL] [Abstract][Full Text] [Related]
16. Soluble phospholipids enhance factor Xa-catalyzed prothrombin activation in solution.
Koppaka V; Wang J; Banerjee M; Lentz BR
Biochemistry; 1996 Jun; 35(23):7482-91. PubMed ID: 8652526
[TBL] [Abstract][Full Text] [Related]
17. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
Villoutreix BO; Dahlbäck B
Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
Krishnaswamy S; Walker RK
Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of soluble phospholipids in the prothrombinase reaction.
Stone MD; Nelsestuen GL
Biochemistry; 2005 Mar; 44(10):4037-41. PubMed ID: 15751980
[TBL] [Abstract][Full Text] [Related]
20. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
Jenkins PV; Dill JL; Zhou Q; Fay PJ
Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
